Exploring ketamine’s potential in the fight against treatment-resistant depression

Major depressive disorder (MDD) is a leading cause of disability worldwide, with a significant proportion of patients (10-20%) progressing to treatment-resistant depression (TRD).

Legend Biotech’s deal with Novartis is a reminder that biotech’s bear market has a few haves, and many have-nots

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Hello, everyone. Damian here

November 14, 2023

Diabetes Projected to Affect 1.3 Billion People by 2050

SAN DIEGO — The total number of people living with diabetes worldwide is expected to more than double over the next 30 years, reported researchers

June 29, 2023

Positive mental well-being can help maintain a physically active lifestyle

According to a recent study, the tendency to experience positive affectivity contributed to people being physically active or even increasing their activity during the COVID-19

January 24, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.